| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |